Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Moodys
Queensland Health
Novartis
Julphar
McKesson
QuintilesIMS
Baxter
Chinese Patent Office
Medtronic

Generated: August 17, 2017

DrugPatentWatch Database Preview

XYLOCAINE Drug Profile

« Back to Dashboard

Which patents cover Xylocaine, and what generic Xylocaine alternatives are available?

Xylocaine is a drug marketed by Oak Pharms, Astrazeneca, Fresenius Kabi Usa, and Dentsply Pharm. and is included in fourteen NDAs.

The generic ingredient in XYLOCAINE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

Summary for Tradename: XYLOCAINE

Patents:0
Applicants:4
NDAs:14
Suppliers / Packagers: see list9
Bulk Api Vendors: see list71
Clinical Trials: see list48
Patent Applications: see list8,702
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:XYLOCAINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
XYLOCAINE W/ EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION006488-019Nov 13, 1986APRXYesYes► Subscribe► Subscribe► Subscribe
Astrazeneca
XYLOCAINE W/ EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION010418-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
XYLOCAINE W/ EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION006488-004Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
XYLOCAINE W/ EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION006488-012Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Oak Pharms
XYLOCAINE
lidocaine hydrochloride
JELLY;TOPICAL008816-001Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Fish and Richardson
Chubb
McKesson
Federal Trade Commission
Moodys
Julphar
Mallinckrodt
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot